During the past decade, Cancer Treatment Centers of America - Eastern Regional Medical Center conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 5 clinical trials were completed, i.e. on average, 45.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Treatment Centers of America - Eastern Regional Medical Center" #1 sponsor was "Genentech, Inc." with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Novartis Pharmaceuticals" with 2 trials sponsored, "Seagen Inc." with 2 trials sponsored and "Astellas Pharma Global Development, Inc." with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Treatment Centers of America - Eastern Regional Medical Center" #1 collaborator was "Covance" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Translational Research in Oncology" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Treatment Centers of America - Eastern Regional Medical Center" are "Non-Small Cell Lung Cancer" (3 trials), "Pancreatic Cancer" (2 trials), "Adult Solid Tumor" (1 trials), "Breast Cancer" (1 trials) and "Cholangiocarcinoma" (1 trials). Many other conditions were trialed in "Cancer Treatment Centers of America - Eastern Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Cancer Treatment Centers of America - Eastern Regional Medical Center" are "Drug" (12 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Alectinib" (2 trials), "Atezolizumab" (2 trials), "Entrectinib" (2 trials), "placebo" (2 trials) and "tucatinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Treatment Centers of America - Eastern Regional Medical Center" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Cancer Treatment Centers of America - Eastern Regional Medical Center". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Cancer Treatment Centers of America - Eastern Regional Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Treatment Centers of America - Eastern Regional Medical Center, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".